ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

DCBDC Advisors Ok Training Grant Program In Clinical Oncology

February 22, 1991

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008